Loading...
•
Sep 30, 2023
Cerus Q3 2023 Earnings Report
Announced financial results for the third quarter ended September 30, 2023
Key Takeaways
Cerus Corporation reported total revenue of $47.3 million for Q3 2023, consisting of $39.8 million in product revenue and $7.5 million in government contract revenue. The company is adjusting its full-year 2023 product revenue guidance to a range of $155 million to $158 million.
Total revenue for Q3 2023 reached $47.3 million, including $39.8 million from product revenue and $7.5 million from government contracts.
Phase 3 ReCePI study enrollment completed in cardiovascular surgery patients, with top-line data expected in Q1 2024.
Cash, cash equivalents, and short-term investments totaled $79.0 million as of September 30, 2023.
Commitment to achieve non-GAAP adjusted EBITDA breakeven reaffirmed for the fourth quarter of 2023.
Cerus
Cerus
Cerus Revenue by Segment
Cerus Revenue by Geographic Location
Revenue by Segment
Product Revenue
CapyFin.comGovernment Contract Revenue
CapyFin.comRevenue by Geographic Location
North America Revenue
CapyFin.comEurope, Middle East and Africa Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
The Company expects full-year 2023 product revenue to be in the range of $155 million to $158 million and remains committed to achieving non-GAAP adjusted EBITDA breakeven during the fourth quarter of 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income